Robert W.a. Sellers - 12 Feb 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
12 Feb 2024
Net transactions value
-$613,552
Form type
4
Filing time
12 Feb 2024, 17:44:54 UTC
Previous filing
15 May 2023
Next filing
23 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $448,718 +12,210 +93% $36.75 25,297 12 Feb 2024 Direct
transaction EW Common Stock Sale $1,062,270 -12,210 -48% $87.00 13,087 12 Feb 2024 Direct
holding EW Common Stock 20,409 12 Feb 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -12,210 -100% $0.000000* 0 12 Feb 2024 Common Stock 12,210 $36.75 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.